UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000033549 |
|---|---|
| Receipt number | R000038257 |
| Scientific Title | Observational research to decide optimal dose of Afatinib in patients with primary lung adenocarcinoma harbouring the sensitive mutation of epidermal growth factor receptor (EGFR) by pharmacokinetic analyses |
| Date of disclosure of the study information | 2018/08/01 |
| Last modified on | 2022/05/28 13:36:14 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/07/28 21:45:43 | ||
| 2 | Update | 2018/10/30 07:30:40 | Recruitment status Anticipated trial start date Other related information |
|
| 3 | Update | 2021/07/30 09:25:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Division name Division name Zip code Address Address TEL Last name of contact person Last name of contact person Organization Organization Division name Division name Zip code Address Address TEL Division name Division name Department Organization Organization Address Address Tel |
|
| 4 | Update | 2021/07/30 09:29:45 | Date of IRB Last follow-up date |
|
| 5 | Update | 2022/05/28 13:28:23 | Recruitment status Last follow-up date |
|
| 6 | Update | 2022/05/28 13:29:27 | Number of participants that the trial has enrolled |
|
| 7 | Update | 2022/05/28 13:36:14 | Other related information Other related information |
